1. Scandinavian Simvastatin Survival Group: Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383–1389 (1994)
2. Sacks FM, Moye LA, Davis BR, Cole TG, Rouleau JL, Nash DT, Pfeffer MA, Braunwald E: Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial. Circulation 97 (15): 1446–52 (1998)
3. Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360, 7–22 (2002)
4. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, Mckillop JH, Packard CJ: West Scotland Coronary Prevention Study Group. Prevention of coronary heart diseasewith pravastatin in men with hypercholesterinämia. New Engl. J. Med. 333, 1301–1307 (1995)
5. Arzneimittelkommission der Deutschen Ärzteschaft: Empfehlungen zur Therapie von Fettstoffwechselstörungen. AVP-Sonderheft Therapieempfehlungen, 2. Auflage (1999)